OM336
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OM336, covering 2025-09-30 to 2025-11-14. Get the full timeline:
Most recent: Clinical Trial Update: OM336 in Seropositive Autoimmune Diseases [Phase 1]